AudioScholar Infectious Disease Weekly (India)

AudioScholar
  • 0.0 (0)
  • Medicine
  • Updated Weekly

Infectious Disease — a weekly podcast briefing of the most significant peer-reviewed infectious disease literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc. Indian-English narration.

  1. 2d ago

    This Week in Infectious Disease — Sep 4, 2026

    Welcome to This Week in Infectious Disease. This week we're covering 10 notable papers spanning outbreak preparedness and filovirus response, drug safety and antimicrobial resistance, and prevention — from measles exposure management to nirsevimab ro… This week's papers: 1. A Multistate Investigation of Serious Adverse Events, including Deaths, following Ceftriaxone Injections, September 2024-August 2025. — Clinical Infectious Diseases 2026 2. Characterizing measles healthcare facility exposures-December 2023-September 2025-New York City. — Clinical Infectious Diseases 2026 3. The underappreciated role of rifampin in shaping the epidemiology of RT027-like Clostridioides difficile lineages. — Journal of Antimicrobial Chemotherapy 2026 4. Ring and community vaccination for Bundibugyo virus outbreak response: a stochastic network modelling study. — The Lancet Infectious Diseases 2026 5. Accelerated qualification of diagnostic tests during an ongoing outbreak of Bundibugyo virus disease: a collaborative analytical validation study. — The Lancet Infectious Diseases 2026 6. In vitro activity profiles and temporal trends in reduced susceptibility to azoles in Coccidioides in the United States. — Antimicrobial Agents and Chemotherapy 2026 7. Varicella zoster virus infection. — Nature Reviews Disease Primers 2026 8. Association between nirsevimab coverage and pediatric emergency department visits for bronchiolitis in 12 European countries: An interrupted time-series analys… — PLOS Medicine 2026 9. Switching from etravirine to doravirine in people with HIV harbouring NNRTI resistance-associated mutations: the DorSwitch pilot study. — Journal of Antimicrobial Chemotherapy 2026 10. Sepsis, endemic and emerging infectious diseases: converging concepts and clinical implications. — The Lancet Infectious Diseases 2026 Listen at https://audioscholar.cc/episode/aujjsppmtf

  2. Aug 29

    This Week in Infectious Disease — Aug 28, 2026

    Welcome to This Week in Infectious Disease. This week we're covering 10 notable papers spanning antibiotic duration and stewardship, tuberculosis and HIV therapeutics, and a cluster of emerging-pathogen surveillance reports from three continents. Let… This week's papers: 1. Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis — New England Journal of Medicine 2026 2. Phage therapy: from basic biology to clinical application — Nature Reviews Microbiology 2026 3. Long-term treatment durability and safety after switching to bictegravir/emtricitabine/tenofovir alafenamide in real-world practice: a 144-week update from the… — International Journal of Antimicrobial Agents 2026 4. Antimicrobial stewardship in low- and middle-income countries: Access versus adherence — PLOS Medicine 2026 5. Antibiotic Resistance in Helicobacter pylori: Pathogenic Mechanisms and Eradication Barriers — International Journal of Antimicrobial Agents 2026 6. Global Spread of Trichophyton indotineae Tracked by Mass Spectrometry Identification Network, 2022-2025 — Emerging Infectious Diseases 2026 7. Posttuberculosis Consequences on Tuberculosis Prevention Effectiveness and Cost-effectiveness among New Immigrants, Canada — Emerging Infectious Diseases 2026 8. Genetic characterization of M. tuberculosis isolates from participants in a Phase 2b randomized trial evaluating the M72/AS01E tuberculosis candidate vaccine — The Journal of Infectious Diseases 2026 9. Emergence of Oropouche Virus, Venezuela, 2025 — Emerging Infectious Diseases 2026 10. Reemergence of Scrub Typhus Associated with Leptotrombidium akamushi Mites and Karp-Like Orientia tsutsugamushi Genotype Bacteria, Japan, 2024-2025 — Emerging Infectious Diseases 2026 Listen at https://audioscholar.cc/episode/a8c9944n26

  3. Aug 22

    This Week in Infectious Disease — Aug 21, 2026

    Welcome to This Week in Infectious Disease. This week we're covering 10 notable papers spanning antimicrobial therapy and stewardship in resource-limited and hospital settings, prevention through vaccines, vector control and supplementation, and infe… This week's papers: 1. Azithromycin with or without cefixime for suspected or culture-confirmed uncomplicated typhoid fever in Nepal, Bangladesh, and Pakistan (ACT-South Asia): a dou… — The Lancet Infectious Diseases 2026 2. Clinical Impact of Rapid Molecular Diagnosis of Bloodstream Infections: A Randomized Controlled Trial. — Clinical Infectious Diseases 2026 3. Severe health-care-associated infections and antimicrobial resistance in an Asian Surveillance Network (ACORN-HAI): a multicentre, prospective cohort study. — The Lancet Infectious Diseases 2026 4. Daily Zinc Supplementation for Infection Prevention in Children With Sickle Cell Anemia: The ZIPS-2 Randomized Clinical Trial. — JAMA 2026 5. Annual vs semi-annual follow-up in low complexity virologically suppressed people with HIV: a randomized interventional trial. — Clinical Infectious Diseases 2026 6. Safety and immunogenicity of the synthetic carbohydrate conjugate vaccine, SF2a-TT15, against Shigella flexneri 2a in infants in Kenya: a phase 2a, age-descend… — The Lancet Infectious Diseases 2026 7. Infective Endocarditis in Solid Organ and Haematopoietic Stem Cell Transplant Recipients (E-IPA Study): a propensity-score-matched retrospective cohort study. — Clinical Infectious Diseases 2026 8. Incidence and Outcomes of Human Adenovirus Infection and Disease in a Multicenter Cohort of Pediatric Allogeneic Hematopoietic Cell Transplant Recipients. — Clinical Infectious Diseases 2026 9. Evaluation of Real-World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir/Lamivudine Fixed-Dose Combination in Treatment-Naive and… — Open Forum Infectious Diseases 2026 10. Epidemiological impact of a dual-action insecticidal coating applied to Aedes aegypti breeding sites on dengue transmission in Colombia: a cluster-randomised t… — The Lancet Infectious Diseases 2026 Listen at https://audioscholar.cc/episode/dkndfuwdrj

  4. Aug 15

    This Week in Infectious Disease — Aug 14, 2026

    Welcome to This Week in Infectious Disease. This week we're covering 7 notable papers spanning diagnostic overreach and risk stratification, influenza prevention and transmission, and the practicalities of dosing and trial design. Let's dive in. We… This week's papers: 1. Quantitative PCR Bacterial Levels Cannot Distinguish Recurrent UTI from Other Non-infectious Urinary Symptoms — Clinical Infectious Diseases 2026 2. Evolution of Untreated Anal High-grade Squamous Intraepithelial Lesions in High-risk Men: A Prospective 5-year Clinical Follow-up in the ANRS-EP57-APACHES study — Clinical Infectious Diseases 2026 3. Whole genome sequencing of influenza virus transmission pairs confirms the efficacy of baloxavir in reducing household transmission — Clinical Infectious Diseases 2026 4. Influenza Vaccination and Symptom Burden in Ambulatory Patients with Confirmed Influenza: Evidence from Case-ascertained Household Transmission Studies — Clinical Infectious Diseases 2026 5. Low Cord Blood Titers Are Associated with Prolonged Maternal RSV Antibody Half-Lives in Preterm Infants — The Journal of Infectious Diseases 2026 6. Therapeutic Drug Monitoring of Aztreonam-Avibactam in Critically Ill Patients with CRKP Infections and Variable Renal Function: A Case Series — International Journal of Antimicrobial Agents 2026 7. Guiding principles for pragmatic randomised trials of tuberculosis treatments — The Lancet Infectious Diseases 2026 Listen at https://audioscholar.cc/episode/tjwm9qwxca

  5. Aug 9

    This Week in Infectious Disease — Aug 8, 2026

    Welcome to This Week in Infectious Disease. This week we're covering 10 notable papers spanning antimicrobial resistance — from new society guidance through to shifting molecular epidemiology and stewardship — plus global infectious disease trials in… This week's papers: 1. Infectious Diseases Society of America 2026 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections — Clinical Infectious Diseases 2026 2. Evaluation of patient centred digital adherence technology for tuberculosis treatment outcomes: pragmatic randomised controlled trial — BMJ 2026 3. Iron or Multiple Micronutrient Powder Supplements With Malaria Chemoprevention in Rural Malawian Children: The IRMA Randomized Clinical Trial — JAMA 2026 4. The Effectiveness of Nirsevimab on Antibiotic Use in Children Using Target Trial Emulation — Clinical Infectious Diseases 2026 5. Clinical characteristics and outcomes of patients with bacteraemia caused by non-carbapenemase-producing, carbapenem-resistant Enterobacterales — Journal of Antimicrobial Chemotherapy 2026 6. Changing molecular epidemiology and resistance patterns of carbapenem-resistant Klebsiella pneumoniae in California long-term acute care hospitals — The Journal of Infectious Diseases 2026 7. The effect of metformin on the pharmacokinetics of rifampicin, isoniazid, and pyrazinamide in adults with tuberculosis — Antimicrobial Agents and Chemotherapy 2026 8. Association between tazobactam-piperacillin exposure and the subsequent emergence in gram-negative rods: Findings from a single-institution cohort study — International Journal of Antimicrobial Agents 2026 9. Early prediction of carbapenem resistance phenotype in ICU-acquired Acinetobacter baumannii infection before susceptibility reporting: a temporally validated s… — International Journal of Antimicrobial Agents 2026 10. A Multistate Analysis of Longitudinal Care Outcomes Among People Newly Linked to Human Immunodeficiency Virus Care in Missouri — Open Forum Infectious Diseases 2026 Listen at https://audioscholar.cc/episode/dx7g6ecwyq

  6. Aug 2

    This Week in Infectious Disease — Aug 1, 2026

    Welcome to This Week in Infectious Disease. This week we're covering 10 notable papers spanning antiretroviral therapy and its metabolic consequences, the hard problems of bone, joint and central nervous system infections, drug safety and regimen sim… This week's papers: 1. Initial HIV Therapy for Adults and Treatment-Associated Weight Gain: The Opti-DOR Randomized Clinical Trial — JAMA 2026 2. A review of Bundibugyo virus and the 2026 outbreak: lessons for epidemic preparedness — The Lancet Infectious Diseases 2026 3. The Clean Margin in Diabetic Foot Osteomyelitis: Conceptual Appeal, Practical Uncertainty — Clinical Infectious Diseases 2026 4. Cerebrospinal Fluid Concentrations of Bedaquiline, Pretomanid, and Linezolid During Curative Treatment of Fluoroquinolone-Resistant Pre-Extensively Drug-Resist… — Open Forum Infectious Diseases 2026 5. Staphylococcus epidermidis implant-associated bone and joint infections: high rates of multiresistance associated with treatment failure — International Journal of Antimicrobial Agents 2026 6. Vonoprazan-Based Dual and Quadruple Therapy with Varying Duration for Helicobacter pylori Eradication: A Multicenter, Randomized Controlled Trial — International Journal of Antimicrobial Agents 2026 7. Pharmacogenomic Variability in Adolescents and Youth with Virologic Rebound While Receiving Injectable Cabotegravir/Rilpivirine: A Multi-case Series — International Journal of Antimicrobial Agents 2026 8. Risk stratification of voriconazole-induced hepatotoxicity through therapeutic drug monitoring combined with the albumin-bilirubin score: a multicenter retrosp… — International Journal of Antimicrobial Agents 2026 9. Evaluating the Effectiveness of Antivirals for COVID-19 in the Post-vaccine, Omicron Era: A Systematic Review and Meta-analysis — Open Forum Infectious Diseases 2026 10. Individual-level Factors Associated With Acute Hospitalization After Medically Attended Acute Gastroenteritis and Norovirus Gastroenteritis in the United State… — Open Forum Infectious Diseases 2026 Listen at https://audioscholar.cc/episode/ezb65u6uqe

  7. Jul 26

    This Week in Infectious Disease — Jul 25, 2026

    Welcome to This Week in Infectious Disease. This week we're covering 6 notable papers spanning pediatric pneumonia trials, microbiome dynamics in transplant recipients, influenza antiviral utilization, tuberculosis biomarkers, and vector-borne and va… This week's papers: 1. Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a… — Lancet (London, England) 2026 2. Enteric Microbiome Features that Contribute to Gram-Negative Bloodstream Infections in Hematopoietic Cell Transplant Recipients Colonized with Fluoroquinolone-… — The Journal of infectious diseases 2026 3. Antiviral Dispensing for Influenza Outpatients Younger Than 65 Years With Comorbidities: A Retrospective Cohort Study. — Open forum infectious diseases 2026 4. Associations Between QuantiFERON-TB Gold Plus IFNγ Concentrations and Progression to Symptomatic Tuberculosis in Global High-Burden TB Settings. — Open forum infectious diseases 2026 5. Genomic and Epidemiologic Insights into Ongoing Measles Outbreak, Israel, 2025-2026. — Emerging infectious diseases 2026 6. Southern Tick-Associated Rash Illness in Pediatric Patient, New York, USA, 2025. — Emerging infectious diseases 2026 Listen at https://audioscholar.cc/episode/zajr27mtx8

  8. Jul 19

    This Week in Infectious Disease — Jul 18, 2026

    Welcome to This Week in Infectious Disease. This week we're covering 6 notable papers spanning major clinical themes, including the optimization of treatment for opportunistic infections in vulnerable pediatric and adult populations, the evolving lan… This week's papers: 1. Empirical treatment with valganciclovir in infants living with HIV and hospitalised with severe pneumonia in Africa: a multicentre, open-label, factorial, rand… — Lancet (London, England) 2026 2. Comparator Choice in Helicobacter pylori Eradication: Tegoprazan-Amoxicillin Dual Therapy Versus an Optimized Bismuth-Containing Quadruple Therapy in a Randomi… — International journal of antimicrobial agents 2026 3. Evaluating Rapid Diagnostics for Severe Infections and Sepsis: A Systematic Review and Meta-analysis on behalf of the Hellenic Microbiological Society and the… — International journal of antimicrobial agents 2026 4. Cefiderocol non-susceptibility among carbapenem-resistant Enterobacterales: Data from the 2024 Antimicrobial Testing Leadership and Surveillance (ATLAS) progra… — International journal of antimicrobial agents 2026 5. Characteristics of Mortality in HIV-negative Cryptococcosis Patients: Analysis of a Cohort of 743 Patients. — Open forum infectious diseases 2026 6. Potential Risks and Benefits of Low-Barrier Access and Monitoring for HIV Preexposure Prophylaxis: A Modeling Study. — The Journal of infectious diseases 2026 Listen at https://audioscholar.cc/episode/fzvfpzb3ey

See All (17)

About

Infectious Disease — a weekly podcast briefing of the most significant peer-reviewed infectious disease literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc. Indian-English narration.

Information